An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of people instantaneously. Currently, various drugs are under investigation to treat an enormously increasing number of COVID-19 patients. This dreadful situation clearly demands an efficient strategy to quickly identif...
Saved in:
Main Authors: | Omkar Indari (Author), Shweta Jakhmola (Author), Elangovan Manivannan (Author), Hem Chandra Jha (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
by: Omkar Indari, et al.
Published: (2022) -
How far have we come?
by: Priscilla Robinson, et al.
Published: (2015) -
Pain Catastrophizing: How Far Have We Come
by: Katarina Simic, et al.
Published: (2024) -
Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations
by: Omkar Indari, et al.
Published: (2021) -
Best Pharmaceuticals for Children: How Far Have We Come?
by: Maryann Mazer-Amirshahi, MD, PharmD, et al.
Published: (2014)